Brookfield (TSX:BN) has drawn fresh attention after agreeing to an $83,750,000 cash settlement proposal tied to TerraForm Power litigation, while separately pushing further into nuclear project development in partnership with The Nuclear Company.
See our latest analysis for Brookfield.
The recent 7 day share price return of 7.31% and 30 day share price return of 11.81% suggest momentum has picked up again. The 1 year total shareholder return of 23.98% and 3 year total shareholder return of more than 2x highlight how longer term holders have been rewarded, despite a small negative year to date share price return of 1.05%.
If this nuclear expansion has caught your attention, it could be a good moment to look across the wider atomic power theme and check out 91 nuclear energy infrastructure stocks
With Brookfield trading at CA$63.42 and a published analyst target of CA$72.95, plus fresh nuclear ambitions and legal overhangs, is there still mispricing on the table, or is the market already baking in future growth?
Most Popular Narrative: 22.9% Undervalued
With Brookfield last closing at CA$63.42 against a fair value estimate of CA$82.23, the most followed narrative points to meaningful upside and focuses on the group’s capital recycling model across real assets and asset management.
Brookfield Corporation is a stock for patient, long-term investors. Its numbers may seem underwhelming at first glance, but the company’s capital recycling strategy, exposure to high-growth industries, and ability to generate steady cash flows make it a solid choice for those seeking stability and growth.
Curious what justifies that higher fair value? The narrative emphasizes recycled capital, recurring fee income, and margin assumptions that you will want to review for yourself.
Result: Fair Value of CA$82.23 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, that upside story still faces risks, including the recent 87% revenue decline and sensitivity to higher financing costs, given Brookfield’s large, asset heavy structure.
Find out about the key risks to this Brookfield narrative.
Next Steps
Given the mix of legal risks, nuclear ambitions, and differing views on value, it makes sense to move quickly and test the narrative against the numbers yourself. To help weigh both the potential upsides and the concerns, start by checking the 1 key reward and 1 important warning sign
Looking for more investment ideas?
If you stop here, you risk missing other opportunities quietly lining up elsewhere. Take a few minutes now to scan the market for fresh ideas.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if Brookfield might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com